Company Profile –  SMILAX is a part of a gigantic parent group Called “RAMKY”. Ramky is 1.3 Billion Dollar Company with CAGR of more than 50%.  SMILAX is well expertised in Manufacturing APIs, Drug Intermediates & Pellets for global generic MNCs/brand pharma companies since 2005.  Smilax Labs is a company backed by a heritage of Trust and Credibility. We pledge to build on our legacy by working hard on a daily basis to earn the trust of customers.  Received “ Outstanding Exports award” in Emerging small companies category from Government of India for 2009 –10 and expected even for the current 2010-2011  Smilax is an Approved Vendor to many prestigious clients, who are among the Top 5 in USA, EU, Japan, Korea, India etc…  All key functions in various departments are headed by best in class pharma professionals. Manufacturing Facilities –  We have 2 State of art manufacturing facilities well Equipped with cGMP compliant manufacturing norms. All our Manufacturing facilities are located in the Indian cities Hyderabad and Vishakhapatnam.  Total Plant built up Area of the facility in Vishakhapatnam is 350,000 Sq.ft and invested about US$70 Million for the infra structure.  One more facility is under construction especially to meet regulated markets requirements & Standards.  Multi- product manufacturing facilities maximize the flexibility of operation processes and capabilities.  Set up 495 KL multiple blocks facility at Pharma city, Visakhapatnam in 2009 and now we aim to reach 1200KL manufacturing capacity very soon.  We ensure the effectiveness of the QMS through a range of activities such as Internal Audits, Corrective & Preventive actions, External Assessment and strict adherence to protocols of in-house SOPs and GMP norms.  EMEA audited both the facilities recently, successful certification is expected very soon  Received CEP from EDQM in 2010 for product OMEPRAZOLE. Many more products like Sartans and proton pump inhibitors are in pipeline for certifications. Research & Development  Focus of R&D is to develop new products, improving quality of existing products & Non Infringing process developments.  A state of the art R&D centre is set up with an investment of US$12Mn.  R&D is well equipped with a Kilo Lab Facility, HPLCs, GCs, FTIR, UV Spectrophotometer, Auto Titrators, Digital Polarimeter & Stability chambers  The R&D is driven by 40 well Qualified and Experienced scientists.  As an outcome we are about to file US DMF for few products within few months.